Baker Bros. Advisors’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,497,526
Closed -$12.3M 98
2025
Q1
$12.3M Hold
2,497,526
0.14% 42
2024
Q4
$7.34M Hold
2,497,526
0.08% 62
2024
Q3
$11.8M Hold
2,497,526
0.12% 50
2024
Q2
$9.62M Hold
2,497,526
0.12% 49
2024
Q1
$13.4M Hold
2,497,526
0.17% 43
2023
Q4
$10.7M Hold
2,497,526
0.12% 46
2023
Q3
$9.79M Hold
2,497,526
0.06% 44
2023
Q2
$25.3M Hold
2,497,526
0.15% 38
2023
Q1
$25.5M Buy
2,497,526
+434,782
+21% +$4.97M 0.14% 33
2022
Q4
$19.3M Hold
2,062,744
0.12% 42
2022
Q3
$30M Hold
2,062,744
0.2% 35
2022
Q2
$27.2M Hold
2,062,744
0.15% 38
2022
Q1
$35.2M Buy
2,062,744
+1,229,508
+148% +$20.9M 0.2% 40
2021
Q4
$21.4M Buy
+833,236
New +$26M 0.1% 58

Other funds holding TSVT

Baker Bros. Advisors's TSVT Position: Q2 2025 in Review

Baker Bros. Advisors sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,497,526 shares — an estimated $12.3M sold.

Baker Bros. Advisors first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $35.2M in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Baker Bros. Advisors reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Baker Bros. Advisors sold 2,497,526 2seventy bio shares in Q2 2025, an estimated $12.3M.
  • Baker Bros. Advisors first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Baker Bros. Advisors's 2seventy bio position peaked at $35.2M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Baker Bros. Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.